Peptris, an AI-driven drug discovery startup, announced a fresh funding round of ₹70 crore to expand its pipeline and accelerate preclinical programs. The capital will be used to scale its AI-led platform and advance its drug discovery efforts. The raise highlights growing investor interest in AI-enabled biotech solutions.
Comments
Want to join the conversation?
Loading comments...